Literature DB >> 12151396

Identification of the Anti-proliferative protein Tob as a MAPK substrate.

Momoko Maekawa1, Eisuke Nishida, Takuji Tanoue.   

Abstract

Mitogen-activated protein kinases (MAPKs) regulate a wide variety of cellular functions by phosphorylating their specific substrates. Here we have identified Tob as a novel substrate of MAPK. Tob, a member of the Tob and B-cell translocation gene anti-proliferative protein family, is shown to negatively regulate the proliferation of osteoblasts and T cells. In this study, our two-hybrid screening has identified Tob as an ERK2-interacting protein. Biochemical analyses have then shown that ERK MAPK (ERK2) and JNK/SAPK (JNK2) bind to and phosphorylate Tob in vitro. ERK catalyzes the phosphorylation more efficiently than JNK. When the ERK pathway is activated in cells, phosphorylation of Tob is induced. An ERK-binding or -docking site locates in the N-terminal portion of Tob, and phosphorylation sites reside in the C-terminal stretch region. The docking is crucial for efficient phosphorylation. Mutant forms of Tob, in which serines are replaced by glutamic acids to mimic phosphorylation, show a much reduced ability to inhibit the cell cycle progression to S phase from G(0)/G(1) phase, as compared with wild-type Tob, indicating that ERK phosphorylation negatively regulates the anti-proliferative function of Tob.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151396     DOI: 10.1074/jbc.M204506200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  A global genomic view on LNX siRNA-mediated cell cycle arrest.

Authors:  Dan Zheng; Shaohua Gu; Yao Li; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

Review 2.  Negative regulators in homeostasis of naïve peripheral T cells.

Authors:  Jaime F Modiano; Lisa D S Johnson; Donald Bellgrau
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  The role of the TOB1 gene in growth suppression of hepatocellular carcinoma.

Authors:  Sheyu Lin; Qingfeng Zhu; Yang Xu; Hui Liu; Junyu Zhang; Jiawei Xu; Honglian Wang; Qing Sang; Qinghe Xing; Jia Fan
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

4.  Phosphorylation state of a Tob/BTG protein, FOG-3, regulates initiation and maintenance of the Caenorhabditis elegans sperm fate program.

Authors:  Myon-Hee Lee; Kyung Won Kim; Clinton T Morgan; Dyan E Morgan; Judith Kimble
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-12       Impact factor: 11.205

Review 5.  Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways.

Authors:  M S Webb; A L Miller; T L Howard; B H Johnson; S Chumakov; Y Fofanov; T Nguyen-Vu; C Y Lin; E B Thompson
Journal:  Mol Cell Endocrinol       Date:  2018-03-26       Impact factor: 4.102

Review 6.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.

Authors:  Michihiko Usui; Yutaka Yoshida; Kunikazu Tsuji; Kaoru Oikawa; Kohei Miyazono; Isao Ishikawa; Tadashi Yamamoto; Akira Nifuji; Masaki Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

8.  Structural basis for the antiproliferative activity of the Tob-hCaf1 complex.

Authors:  Masataka Horiuchi; Kosei Takeuchi; Nobuo Noda; Nobuyuki Muroya; Toru Suzuki; Takahisa Nakamura; Junko Kawamura-Tsuzuku; Kiyohiro Takahasi; Tadashi Yamamoto; Fuyuhiko Inagaki
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

9.  Mice lacking a transcriptional corepressor Tob are predisposed to cancer.

Authors:  Yutaka Yoshida; Takahisa Nakamura; Masato Komoda; Hitoshi Satoh; Toru Suzuki; Junko K Tsuzuku; Takashi Miyasaka; Eri H Yoshida; Hisashi Umemori; Reiko K Kunisaki; Kenzaburo Tani; Shunsuke Ishii; Shigeo Mori; Masami Suganuma; Tetsuo Noda; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

Review 10.  BTG/TOB factors impact deadenylases.

Authors:  Fabienne Mauxion; Chyi-Ying A Chen; Bertrand Séraphin; Ann-Bin Shyu
Journal:  Trends Biochem Sci       Date:  2009-10-12       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.